Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
EJNMMI Research
Published in: EJNMMI Research 1/2020

Open Access 01-12-2020 | Prostate Cancer | Correction

Correction to: Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

Authors: M. I. Ross, N. Bird, I. A. Mendichovszky, Y. L. Rimmer

Published in: EJNMMI Research | Issue 1/2020

Login to get access

Excerpt

Following publication of the original article [1], the authors have reported that there are two errors concerning the representation of the PET imaging agent ‘[68Ga]Ga-THP-PSMA PET/CT’; one error affects the article title, and the other affects the caption of Fig. 2. …
Literature
1.
Metadata
Title
Correction to: Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT
Authors
M. I. Ross
N. Bird
I. A. Mendichovszky
Y. L. Rimmer
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
EJNMMI Research / Issue 1/2020
Electronic ISSN: 2191-219X
DOI
https://doi.org/10.1186/s13550-020-00719-w

Other articles of this Issue 1/2020

EJNMMI Research 1/2020 Go to the issue

Original research

Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson’s disease: a longitudinal study

Original research

Indium-111-labeled CD166-targeted peptide as a potential nuclear imaging agent for detecting colorectal cancer stem-like cells in a xenograft mouse model

Original research

Diagnostic value of PET/CT with 11C-methionine (MET) and 18F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification

Original research

Predictive value of quantitative 18F-FDG-PET radiomics analysis in patients with head and neck squamous cell carcinoma

Original research

Kinfitr — an open-source tool for reproducible PET modelling: validation and evaluation of test-retest reliability

Original research

PD-L1 expression correlation with metabolic parameters of FDG PET/CT and clinicopathological characteristics in non-small cell lung cancer